BIOMAT Database Logo BIOMAT Database Logo

Maternal serum interleukin-6 level in preterm labor. 2013

Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Department of Biochemistry, University of Ondokuz Mayis, School of Medicine, Kurupelit, Samsun-Turkey.

OBJECTIVE The aim of this study was to measure interleukin-6 (IL-6) levels in maternal serum of women undergoing preterm labor without a clear infection. METHODS Twenty two pregnant women with diagnosis of preterm labor who presented to the outpatient clinic of 19 Mayis University Faculty of Medicine from July 2011 through December 2011 were enrolled in the study group. Twenty two healthy pregnant women who were at the same gestational age as the study group were selected as the control group. RESULTS Gestational age in the study and control groups varied from 24 weeks and 4 days to 34 weeks and 6 days. In the study group, 11 patients (50%) underwent preterm birth. Pregnant women in preterm labor were compared to healthy pregnant women with regards to serum IL-6 levels. No significant difference was found in the IL-6 levels of maternal serum between the 2 groups. CONCLUSIONS In this study we have shown that there is no increase in lL-6 levels in patients undergoing preterm labor without clinical or biochemical infection signs.

UI MeSH Term Description Entries
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011295 Prenatal Care Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. Antenatal Care,Care, Antenatal,Care, Prenatal
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Maternal serum interleukin-6 during pregnancy and during term and preterm labor.
September 1997, Obstetrics and gynecology,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Predictive value of maternal serum and vaginal interleukin-6 levels in preterm labor.
May 2005, Journal of the Society for Gynecologic Investigation,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-alpha and interferon-gamma in preterm labor.
June 2003, Acta obstetricia et gynecologica Scandinavica,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Maternal serum interleukin 6 levels in preterm labor: prediction of admission-to-delivery interval.
January 2000, Journal of perinatal medicine,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Maternal serum interleukin 1, 2, 6, 8 and interleukin-2 receptor levels in preterm labor and delivery.
January 2000, European journal of obstetrics, gynecology, and reproductive biology,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
[Maternal plasma and amniotic fluid interleukin-6 levels in imminent preterm labor].
August 2000, Ginekologia polska,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Maternal serum interleukin 6 and 8 and C-reactive protein in predicting the tocolytic therapy in preterm labor.
June 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis.
May 1994, American journal of obstetrics and gynecology,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Maternal Serum and Cervicovaginal IL-6 in Patients with Symptoms of Preterm Labor.
September 2016, Iranian journal of immunology : IJI,
Yüksel Işik, and Handan Celik, and Bahattin Avci, and Miğraci Tosun, and Devran Bildircin, and Erdal Malatyalioğlu, and Tayfun Alper
Dysregulation of maternal serum adiponectin in preterm labor.
October 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Copied contents to your clipboard!